FDA-Drug2026-10-23Class IIPROCESSING DEFECT
Safecor Health metoclopramide 5 mg tablets recalled for co-mingled tablet contamination
What this means
Safecor Health is recalling specific batches of metoclopramide 5 mg tablets manufactured for Teva Pharmaceuticals due to co-mingled tablets in the bottles. Co-mingling means tablets from different batches or products may have been mixed together. The affected lot is 3116509 with an expiry date of 07/31/2027.
- Check if you have metoclopramide 5 mg tablets from lot #3116509 (expiry 07/31/2027)
- Contact your pharmacy or healthcare provider if you have this lot
- Do not use tablets from the recalled lot without speaking to your pharmacist or doctor first
The agency's original wording
Hazard
Manufacturer is recalling batches due to co-mingled tablet.
Intended for
Adults
Illnesses reported
None reported
Sold states
US Nationwide
Manufactured in
1718 Northrock Ct, Rockford, Illinois, United States
Products
Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079-886-20.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0075-2027More Safecor Health recalls
- FDA-Drug2026-09-23Safecor Health Fluphenazine HCl Elixir recalled for failed stability specifications
- FDA-Drug2026-09-23Safecor Health Fluphenazine HCl Elixir recalled for failed stability specifications
- FDA-Drug2026-09-23Safecor Health Fluphenazine HCl Elixir recalled for failed stability specifications
- FDA-Drug2026-09-23Safecor Health Fluphenazine HCl Elixir recalled for failed stability specifications
- FDA-Drug2026-09-23Safecor Health Fluphenazine HCl Elixir recalled for failed stability specifications
Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.